X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Pidilite Industries - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs PIDILITE INDUSTRIES - Comparison Results

PIDILITE INDUSTRIES 
   Change

Pidilite is present in consumer products and speciality industrial products.Consumer products with a 79% sales share include art materials, adhesives, sealants, fabric care and car care products. Industrial products consist of adhesives, pigments, le... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES PIDILITE INDUSTRIES AMAR REMEDIES/
PIDILITE INDUSTRIES
 
P/E (TTM) x -0.5 66.3 - View Chart
P/BV x 0.1 14.8 0.4% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 AMAR REMEDIES   PIDILITE INDUSTRIES
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
PIDILITE INDUSTRIES
Mar-19
AMAR REMEDIES/
PIDILITE INDUSTRIES
5-Yr Chart
Click to enlarge
High Rs1641,249 13.1%   
Low Rs86898 9.6%   
Sales per share (Unadj.) Rs261.6139.4 187.7%  
Earnings per share (Unadj.) Rs17.418.3 95.2%  
Cash flow per share (Unadj.) Rs22.320.9 106.7%  
Dividends per share (Unadj.) Rs06.50 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs100.781.7 123.4%  
Shares outstanding (eoy) m26.16507.98 5.1%   
Bonus/Rights/Conversions -ESOS-  
Price / Sales ratio x0.57.7 6.2%   
Avg P/E ratio x7.258.7 12.2%  
P/CF ratio (eoy) x5.651.4 10.9%  
Price / Book Value ratio x1.213.1 9.4%  
Dividend payout %035.6 0.0%   
Avg Mkt Cap Rs m3,270545,291 0.6%   
No. of employees `000NA5.7 0.0%   
Total wages/salary Rs m1638,367 1.9%   
Avg. sales/employee Rs ThNM12,328.0-  
Avg. wages/employee Rs ThNM1,457.1-  
Avg. net profit/employee Rs ThNM1,616.8-  
INCOME DATA
Net Sales Rs m6,84470,787 9.7%  
Other income Rs m211,466 1.4%   
Total revenues Rs m6,86572,254 9.5%   
Gross profit Rs m1,13113,538 8.4%  
Depreciation Rs m1281,327 9.6%   
Interest Rs m398261 152.7%   
Profit before tax Rs m62613,416 4.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m1214,132 2.9%   
Profit after tax Rs m4559,284 4.9%  
Gross profit margin %16.519.1 86.4%  
Effective tax rate %19.330.8 62.8%   
Net profit margin %6.613.1 50.7%  
BALANCE SHEET DATA
Current assets Rs m4,90435,820 13.7%   
Current liabilities Rs m3,58115,593 23.0%   
Net working cap to sales %19.328.6 67.7%  
Current ratio x1.42.3 59.6%  
Inventory Days Days12448 257.9%  
Debtors Days Days10054 183.9%  
Net fixed assets Rs m1,68917,142 9.9%   
Share capital Rs m262508 51.6%   
"Free" reserves Rs m2,35840,973 5.8%   
Net worth Rs m2,63541,481 6.4%   
Long term debt Rs m50785 595.8%   
Total assets Rs m6,86259,145 11.6%  
Interest coverage x2.652.5 4.9%   
Debt to equity ratio x0.20 9,378.8%  
Sales to assets ratio x1.01.2 83.3%   
Return on assets %12.416.1 77.0%  
Return on equity %17.322.4 77.2%  
Return on capital %31.032.9 94.2%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2735,430 5.0%   
Fx outflow Rs m29,720 0.0%   
Net fx Rs m271-4,290 -6.3%   
CASH FLOW
From Operations Rs m-3138,448 -3.7%  
From Investments Rs m-489-5,131 9.5%  
From Financial Activity Rs m769-3,606 -21.3%  
Net Cashflow Rs m-33-183 17.8%  

Share Holding

Indian Promoters % 25.5 69.5 36.7%  
Foreign collaborators % 0.0 0.6 -  
Indian inst/Mut Fund % 9.2 3.5 262.9%  
FIIs % 0.0 15.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 10.7 610.3%  
Shareholders   13,061 44,398 29.4%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   BAJAJ CONSUMER CARE  GODREJ CONSUMER  GILLETTE INDIA  EMAMI LTD  KARUTURI GLOBAL  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Indian Indices Witness Selling, HDFC Q1FY20 Results, and Top Cues in Focus Today(Pre-Open)

India share markets ended their day deep in the red yesterday. At the closing bell yesterday, the BSE Sensex stood lower by 305 points (down 0.8%).

Related Views on News

PIDILITE INDUSTRIES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 12, 2019 | Updated on Jul 12, 2019

Here's an analysis of the annual report of PIDILITE INDUSTRIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIDILITE INDUSTRIES. Also includes updates on the valuation of PIDILITE INDUSTRIES.

PIDILITE INDUSTRIES Announces Quarterly Results (4QFY19); Net Profit Down 5.1% (Quarterly Result Update)

May 16, 2019 | Updated on May 16, 2019

For the quarter ended March 2019, PIDILITE INDUSTRIES has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 16 bn (up 10.3% YoY). Read on for a complete analysis of PIDILITE INDUSTRIES's quarterly results.

PIDILITE INDUSTRIES Announces Quarterly Results (3QFY19); Net Profit Down 8.8% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PIDILITE INDUSTRIES has posted a net profit of Rs 2 bn (down 8.8% YoY). Sales on the other hand came in at Rs 18 bn (up 19.8% YoY). Read on for a complete analysis of PIDILITE INDUSTRIES's quarterly results.

PIDILITE INDUSTRIES Announces Quarterly Results (2QFY19); Net Profit Down 8.6% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, PIDILITE INDUSTRIES has posted a net profit of Rs 2 bn (down 8.6% YoY). Sales on the other hand came in at Rs 18 bn (up 14.9% YoY). Read on for a complete analysis of PIDILITE INDUSTRIES's quarterly results.

PIDILITE INDUSTRIES 2017-18 Annual Report Analysis (Annual Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

Here's an analysis of the annual report of PIDILITE INDUSTRIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PIDILITE INDUSTRIES. Also includes updates on the valuation of PIDILITE INDUSTRIES.

More Views on News

Most Popular

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

7 Stocks to Profit From an Irreversible Trend(The 5 Minute Wrapup)

Jul 18, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS